A technique to create hydrogels with tethered concentration gradients of molecules <i>in vitro</i>
O'Shea TC., Salem A., Schultz KM.
Laboratory Study, published in Soft Matter (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Soft Matter (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41480738
- PMCID
- PMC12757908
- DOI
- 10.1039/d5sm01194a
Abstract (original English)
This work develops a technique to create and quantify tethered molecular concentration gradients in a hydrogel using a flow chamber. This device is designed to enable isotropic scaffold swelling, nutrient diffusion and real-time microrheological measurements. A hydrogel is first photopolymerized in the flow chamber ensuring that the mechanical properties of the hydrogel across samples are the same prior to molecular concentration gradient creation. Then molecules are passively diffused into the scaffold and a second photopolymerization tethers the concentration gradient into the material. This technique creates in vitro mimics of aspects of biological environments, such as the environment around a hydrogel implanted in the body for cell delivery. We use a well-defined synthetic scaffold with a poly(ethylene glycol) (PEG)-norbornene backbone cross-linked with a matrix metalloproteinase (MMP)-degradable peptide, a standard material for cell encapsulation. The method to tether molecular concentration gradients is validated using a fluorescent PEG-thiol (FITC-PEG-SH), an ideal polymer. We first create a calibration curve by measuring the fluorescence intensity of hydrogels with known uniform concentrations of the tethered fluorescent molecule. The calibration curve is used to calculate spatial concentration from measured fluorescence intensity in hydrogels with polymer or protein c
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.